Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Alkem Laboratories Limited, is an unlisted public company incorporated on 08 August, 1973. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 50.00 cr and the total paid-up capital is INR 23.91 cr.
Alkem Laboratories Limited's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 23.94% over the previous year. At the same time, it's book networth has increased by 6.93%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
CS | Manish Narang
Shareholder
|
<HIDDEN> | 18 years |
Director | Arun Kumar Purwar | 00026383 | 10 years |
Director | Narendra Aneja | 00124302 | 5 years |
Whole-time Director | Basudeo Narayan Singh
Shareholder
|
00760310 | 52 years |
Whole-time Director | Mritunjay Kumar Singh
Shareholder
|
00881412 | 17 years |
Director | Rajeev Kher | 01192524 | 1 years |
Managing Director | Sandeep Singh
Shareholder
|
01277984 | 12 years |
Whole-time Director | Sarvesh Singh
Shareholder
|
01278229 | 6 years |
Director | Sujjain Suresh Talwar | 01756539 | 3 years |
Whole-time Director | Srinivas Balmiki Prasad Singh
Shareholder
|
06744441 | 3 years |
Director | Sudha Ravi | 06764496 | 10 years |
Director | Sangeeta Kapil Jit Singh | 06920906 | 10 years |
Kmp | Nitin Agrawal | <HIDDEN> | 1 years |
Whole-time Director | Madhurima Singh
Shareholder
|
09137323 | 3 years |
Kmp | Vikas Gupta | <HIDDEN> | 2 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CitiBank N.A.
No. of Loans: 1
Total Amount : 342.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 270.3 cr
Kotak Mahindra Bank Limited
No. of Loans: 2
Total Amount : 180.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 108.0 cr
State Bank of India
No. of Loans: 2
Total Amount : 100.2 cr
Bank of India
No. of Loans: 1
Total Amount : 85.0 cr
MEMBER SECRETARY SINGLE WINDOW CLEARANCE AGENCY
No. of Loans: 1
Total Amount : 0.3 cr
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
Ascend Laboratories SDN BHD | Malaysia | - | - |
S & B Holdings B.V | Netherlands | - | - |
Pharmacor Limited | New Zealand | - | - |
Alkem Laboratories Corporation | Philippines | - | - |
Enzene Inc | United States | - | - |
Ascend Laboratories (Pty) Limited (formerly known as Alkem Laboratories (Pty) Limited) | South Africa | - | - |
ThePharmaNetwork, LLC | United States | - | - |
Ascend Laboratories LLC | United States | - | - |
Ascend Laboratories (UK) Limited | United Kingdom | - | - |
ALKEM FOUNDATION | Maharashtra | 2010 | ₹ 1.0 L |
Pharmacor Pty Limited | Australia | - | - |
Ascend Laboratories Limited | Canada | - | - |
Pharma Network SpA | Chile | - | - |
Ascend Laboratories SAS | Colombia | - | - |
CONNECT 2 CLINIC PRIVATE LIMITED | Maharashtra | 2020 | ₹ 1.5 Cr |
S&B Pharma LLC | United States | - | - |
CACHET PHARMACEUTICALS PRIVATE LIMITED | Bihar | 1978 | ₹ 17.8 L |
Ascend Laboratories SpA | Chile | - | - |
ENZENE BIOSCIENCES LIMITED | Maharashtra | 2006 | ₹ 51.3 Cr |
Ascend GmbH (Formerly known as Alkem Pharma GmbH) | Germany | - | - |
INDCHEMIE HEALTH SPECIALITIES PRIVATE LIMITED | Maharashtra | 1986 | ₹ 25.0 L |
The PharmaNetwork, LLP | Kazakhstan | - | - |
Alkem Laboratories Korea Inc | Korea, Republic Of | - | - |
Ascend Laboratories S.A. DE C.V | Mexico | - | - |
ALKEM MEDTECH PRIVATE LIMITED | Indonesia | - | - |
S&B Holdings S.a.r.l. (Previously known as S&B Holdings B.V with principle place of business based a | Netherlands | - | - |
Ascend Laboratories (Pty) Limited | South Africa | - | - |
Ascend GmbH | Germany | - | - |
Ascend Laboratories S.A. DE C.V. | Mexico | - | - |
ALKEM MEDTECH PRIVATE LIMITED | India | - | - |
Read more
The incorporation date of ALKEM LABORATORIES LIMITED is 08 August, 1973
The authorized share capital of ALKEM LABORATORIES LIMITED is INR ₹ 50.0 Cr.
The paid-up capital of ALKEM LABORATORIES LIMITED is INR ₹ 23.9 Cr.
The registered address of ALKEM LABORATORIES LIMITED is ALKEM HOUSE, SENAPATI BAPAT MARG LOWER PAREL MUMBAI Maharashtra - 400013
The CIN number of ALKEM LABORATORIES LIMITED is L00305MH1973PLC174201.